UZH researchers have developed a novel therapy for multiple sclerosis that is designed to stop the misguided immune response without suppressing the immune system as a whole.

A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application.

BeOne Medicines, Ltd., a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S…

Children whose appendix has burst often develop serious abdominal infections that are hard to treat and increasingly resistant to antibiotics. In a recent study, researchers tested whether a light-activated blue…

A prospective cohort study of 1,935 mother-child pairs examined whether baby swimming during the first 6 months of life was associated with IQ and cognitive performance at ages 4 to…

A cross-sectional study of children aged 4 to 9 found that greater caregiver-reported daily screen time was associated with lower contrast sensitivity and differences in how age related to visual-search…

Regular aerobic exercise – the kind that gets your heart pumping – can improve important thinking skills called executive functions, and the benefits appear especially strong for women after menopause,…

New research from the Marshall University Joan C. Edwards School of Medicine provides insight into how binge alcohol exposure during adolescence may cause lasting changes in brain function that persist…

A narrative review suggests GLP-1-based therapies deliver metabolic, cardiovascular, renal, and other systemic benefits, raising interest in whether lower fractional doses could improve tolerability and treatment continuity. However, direct evidence…

One of Australia's largest real world studies of younger adults with advanced bowel cancer has identified important differences between cancers diagnosed before and after the age of 50, which could…